CJ Bioscience, 40 Billion KRW Paid-in Capital Increase... Allocated to CJ CheilJedang
CJ Bioscience announced on the 9th that it has decided to raise 40 billion KRW through a third-party allotment paid-in capital increase to secure operating funds. A total of 3,952,960 new common shares will be issued at 10,119 KRW per share. The third-party allotment recipient is the largest shareholder, CJ CheilJedang (3,952,960 shares).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.